Search Results

There are 2448734 results for: content related to: Interaction Between Sibutramine and Cyclosporine

  1. An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action

    Obesity Reviews

    Volume 1, Issue 2, October 2000, Pages: 127–139, E. Nisoli and M. O. Carruba

    Article first published online : 25 DEC 2001, DOI: 10.1046/j.1467-789x.2000.00020.x

  2. You have free access to this content
    NPY5R Antagonism Does Not Augment the Weight Loss Efficacy of Orlistat or Sibutramine

    Obesity

    Volume 15, Issue 8, August 2007, Pages: 2027–2042, Ngozi Erondu, Carol Addy, Kaifeng Lu, Madhuja Mallick, Bret Musser, Ira Gantz, Joseph Proietto, Arne Astrup, Søren Toubro, Aila M. Rissannen, Serena Tonstad, William G. Haynes, Keith M. Gottesdiener, Keith D. Kaufman, John M. Amatruda and Steven B. Heymsfield

    Article first published online : 6 SEP 2012, DOI: 10.1038/oby.2007.242

  3. Effects of Clopidogrel on the Pharmacokinetics of Sibutramine and Its Active Metabolites

    The Journal of Clinical Pharmacology

    Volume 51, Issue 12, December 2011, Pages: 1704–1711, Jung-Woo Bae, Choon-Gon Jang and Seok-Young Lee

    Article first published online : 12 MAR 2013, DOI: 10.1177/0091270010388651

  4. Association of CYP2B6, CYP3A5, and CYP2C19 Genetic Polymorphisms With Sibutramine Pharmacokinetics in Healthy Korean Subjects

    Clinical Pharmacology & Therapeutics

    Volume 86, Issue 5, November 2009, Pages: 511–518, KA Kim, WK Song and JY Park

    Article first published online : 19 AUG 2009, DOI: 10.1038/clpt.2009.145

  5. You have free access to this content
    Effects of Sibutramine Plus Orlistat in Obese Women Following 1 Year of Treatment by Sibutramine Alone: A Placebo-Controlled Trial

    Obesity Research

    Volume 8, Issue 6, September 2000, Pages: 431–437, Thomas A. Wadden, Robert I. Berkowitz, Leslie G. Womble, David B. Sarwer, Marjorie E. Arnold and Carrie M. Steinberg

    Article first published online : 6 SEP 2012, DOI: 10.1038/oby.2000.53

  6. You have free access to this content
    The Safety Profiles of Orlistat and Sibutramine: Results of Prescription-Event Monitoring Studies in England

    Obesity

    Volume 15, Issue 11, November 2007, Pages: 2712–2722, Michael J. Perrio, Lynda V. Wilton and Saad A. W. Shakir

    Article first published online : 6 SEP 2012, DOI: 10.1038/oby.2007.323

  7. You have free access to this content
    Peripheral Mechanisms of Sibutramine Involving Proximal Gastric Motility in Dogs

    Obesity

    Volume 14, Issue 8, August 2006, Pages: 1363–1370, Junying Xu and Jiande D.Z. Chen

    Article first published online : 6 SEP 2012, DOI: 10.1038/oby.2006.154

  8. A systematic review and mixed treatment comparison of pharmacological interventions for the treatment of obesity

    Obesity Reviews

    Volume 13, Issue 6, June 2012, Pages: 483–498, L. J. Gray, N. Cooper, A. Dunkley, F. C. Warren, R. Ara, K. Abrams, M. J. Davies, K. Khunti and A. Sutton

    Article first published online : 30 JAN 2012, DOI: 10.1111/j.1467-789X.2011.00981.x

  9. Long-term effects of weight-reducing drugs in people with hypertension

    Intervention Review

    The Cochrane Library

    Andrea Siebenhofer, Klaus Jeitler, Karl Horvath, Andrea Berghold, Nicole Posch, Jutta Meschik and Thomas Semlitsch

    Published Online : 2 MAR 2016, DOI: 10.1002/14651858.CD007654.pub4

  10. You have free access to this content
    Influence of Sibutramine on Energy Expenditure in African American Women

    Obesity Research

    Volume 9, Issue 4, April 2001, Pages: 251–256, Raymond D. Starling, Xiaolan Liu and Dennis H. Sullivan

    Article first published online : 6 SEP 2012, DOI: 10.1038/oby.2001.29

  11. You have free access to this content
    5-HT1A Activation Counteracts Cardiovascular But Not Hypophagic Effects of Sibutramine in Rats

    Obesity

    Volume 17, Issue 3, March 2009, Pages: 467–473, Gerard H. Thomas, Adam J. Babbs, Rosemary E. Chatfield, Thomas M. Krülle, Peter S. Widdowson, Daniel Provost and James G. McCormack

    Article first published online : 6 SEP 2012, DOI: 10.1038/oby.2008.550

  12. You have free access to this content
    Six-Month Treatment of Obesity with Sibutramine 15 mg; A Double-Blind, Placebo-Controlled Monocenter Clinical Trial in a Hispanic Population

    Obesity Research

    Volume 8, Issue 1, January 2000, Pages: 71–82, Guillermina Elisa Martínez Cuellar, Alberto Martínez Ruiz, Maria Cristina Revilla Monsalve and Dr. Arturo Berber

    Article first published online : 6 SEP 2012, DOI: 10.1038/oby.2000.10

  13. Sibutramine-associated adverse effects: a practical guide for its safe use

    Obesity Reviews

    Volume 9, Issue 4, July 2008, Pages: 378–387, M. Florentin, E. N. Liberopoulos and M. S. Elisaf

    Article first published online : 23 NOV 2007, DOI: 10.1111/j.1467-789X.2007.00425.x

  14. Proteome changes in rat plasma in response to sibutramine

    PROTEOMICS

    Volume 11, Issue 7, April 2011, Pages: 1300–1312, Jung-Won Choi, Jeong In Joo, Dong Hyun Kim, Xia Wang, Tae Seok Oh, Duk Kwon Choi and Jong Won Yun

    Article first published online : 17 FEB 2011, DOI: 10.1002/pmic.201000664

  15. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus

    Intervention Review

    The Cochrane Library

    Susan L Norris, Xuanping Zhang, Alison Avenell, Edward Gregg, Christopher H Schmid and Joseph Lau

    Published Online : 24 JAN 2005, DOI: 10.1002/14651858.CD004096.pub2

  16. You have free access to this content
    Regulation of Body Weight and Carcass Composition by Sibutramine in Rats

    Obesity Research

    Volume 10, Issue 3, March 2002, Pages: 173–181, Dr. Alison M. Strack, Joanne Shu, Ramon Camacho, Judith N. Gorski, Beth Murphy, D. Evan MacIntyre and Gerard J. Hickey

    Article first published online : 6 SEP 2012, DOI: 10.1038/oby.2002.27

  17. Sibutramine is effective for weight loss and diabetic control in obesity with type 2 diabetes: a randomised, double-blind, placebo-controlled study

    Diabetes, Obesity and Metabolism

    Volume 2, Issue 2, March 2000, Pages: 105–112, N. Finer, S. R. Bloom, G. S. Frost, L. M. Banks and J. Griffiths

    Article first published online : 25 DEC 2001, DOI: 10.1046/j.1463-1326.2000.00071.x

  18. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success

    Diabetes, Obesity and Metabolism

    Volume 10, Issue 6, June 2008, Pages: 498–505, K. Elfhag, N. Finer and S. Rössner

    Article first published online : 26 JUN 2007, DOI: 10.1111/j.1463-1326.2007.00740.x

  19. You have free access to this content
    Modulation of sibutramine-induced increases in extracellular noradrenaline concentration in rat frontal cortex and hypothalamus by α2-adrenoceptors

    British Journal of Pharmacology

    Volume 128, Issue 3, October 1999, Pages: 659–666, K E Wortley, D J Heal and S C Stanford

    Article first published online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0702859

  20. You have free access to this content
    The anorexic agents, sibutramine and fenfluramine, depress GABAB-induced inhibitory postsynaptic potentials in rat mesencephalic dopaminergic cells

    British Journal of Pharmacology

    Volume 156, Issue 6, March 2009, Pages: 962–969, Ada Ledonne, Luca Sebastianelli, Mauro Federici, Giorgio Bernardi and Nicola Biagio Mercuri

    Article first published online : 9 MAR 2009, DOI: 10.1111/j.1476-5381.2008.00081.x